Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2023-11-16 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
董事、监事换届公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the change of the company's board of directors and supervisors, including details about nominations, qualifications, and resolutions passed in board meetings. It does not contain financial statements or performance data, nor is it a report or presentation. The content focuses on management changes and governance structure updates. The document length is 3494 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2023-11-16 Chinese
股东大会议事规则公告
Governance Information Classification · 95% confidence The document is titled as the "Shareholders' Meeting System" of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the rules, procedures, and powers related to the company's shareholders' meetings, including the convening, proposal submission, voting, and resolution announcement processes. It is a comprehensive governance document outlining internal rules and procedures for shareholder meetings rather than a report of financial results, audit, or management changes. There is no indication that this is a report of an actual meeting or voting results, nor is it a presentation or announcement of financial data. The content aligns with governance information about the company's internal rules and board/shareholder meeting procedures. Therefore, the most appropriate classification is Governance Information (CGR). The document length (13,478 characters) supports that this is a full governance document, not a brief announcement or notice.
2023-11-16 Chinese
监事会议事规则
Governance Information Classification · 100% confidence The document is titled '江苏森萱医药股份有限公司监事会议事规则' which translates to 'Supervisory Board Meeting Rules' of the company. It details the rules, procedures, powers, composition, meeting notices, proposal rules, meeting discussions, resolutions, and post-meeting matters related to the supervisory board. It references relevant laws and company articles but does not contain financial statements, audit opinions, or financial results. It is a governance document outlining internal rules and procedures for the supervisory board. There is no indication that this is an announcement or a brief notice; it is a full detailed document of governance rules. Therefore, the document fits best under Governance Information (CGR).
2023-11-16 Chinese
2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the "2023 Second Extraordinary General Meeting of Shareholders" of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the meeting date, attendance, voting results on a proposal to renew the accounting firm, and legal opinions confirming the validity of the meeting and voting process. The content focuses on the official announcement of voting results from a shareholders' meeting rather than the meeting materials or the full report itself. The document length is short (1474 characters), and it serves as an official disclosure of voting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-11-16 Chinese
独立董事年报工作规程
Governance Information Classification · 95% confidence The document is titled as a work procedure for independent directors related to the annual report preparation and disclosure process. It details the responsibilities and duties of independent directors in overseeing the annual report, including communication with auditors, confidentiality, and compliance with regulatory requirements. There is no actual financial data or audit results presented, nor is this a report or announcement of voting results. The document is a governance-related procedural document concerning the internal control and oversight of the annual report process. Therefore, it fits best under Governance Information (CGR). The document length is short (1823 characters), and it is not an announcement of a report publication but a procedural regulation document.
2023-11-16 Chinese
累积投票制实施细则
Governance Information Classification · 95% confidence The document is a detailed announcement from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the implementation rules of cumulative voting system for electing directors and supervisors. It includes procedural details, nomination and election rules, and voting rights explanations. The document is not a financial report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement but rather a governance-related document detailing internal election procedures and governance structure improvements. The document length is 3105 characters, which is relatively short but contains substantive governance content rather than just an announcement or notice. Therefore, it fits best under Governance Information (CGR).
2023-11-16 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.